Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yi Ching Esther Wan

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Biomedicines|July 2, 2021
Histone H2B Mutations in CancerYi Ching Esther Wan, Kui Ming Chan
Current Pharmacology Reports|August 14, 2018
Histone H3 Mutations in CancerYi Ching Esther Wan, Jiaxian Liu, Kui Ming Chan
Genesis (New York, N.Y. : 2000)|April 22, 2022
Lrwd1 impacts cell proliferation and the silencing of repetitive DNA elementsTze Zhen Evangeline Kang, Yi Ching Esther Wan, Zhiguo Zhang, et al.
Nature Communications|August 17, 2023
ATF3 induction prevents precocious activation of skeletal muscle stem cell by regulating H2B expressionSuyang Zhang, Feng Yang, Yile Huang, et al.
Cell Reports|November 24, 2025
Dual inhibition of FACT and RRM2 suppresses the progression of pancreatic ductal adenocarcinoma driven by the oncohistone H2BG53DTiantian Qin, Yi Ching Esther Wan, Shiman Hu, et al.
The Journal of Biological Chemistry|February 6, 2021
The elevated transcription of ADAM19 by the oncohistone H2BE76K contributes to oncogenic properties in breast cancerTze Zhen Evangeline Kang, Lina Zhu, Du Yang, et al.
Science Advances|July 10, 2026
H2BE113K mutation promotes breast cancer metastasis through modulating chromatin dynamicsShiman Hu 胡诗曼, Jiaxian Liu, Jiaqi Zhou, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Biomedicines|July 2, 2021
Histone H2B Mutations in CancerYi Ching Esther Wan, Kui Ming Chan
Current Pharmacology Reports|August 14, 2018
Histone H3 Mutations in CancerYi Ching Esther Wan, Jiaxian Liu, Kui Ming Chan
Genesis (New York, N.Y. : 2000)|April 22, 2022
Lrwd1 impacts cell proliferation and the silencing of repetitive DNA elementsTze Zhen Evangeline Kang, Yi Ching Esther Wan, Zhiguo Zhang, et al.
Nature Communications|August 17, 2023
ATF3 induction prevents precocious activation of skeletal muscle stem cell by regulating H2B expressionSuyang Zhang, Feng Yang, Yile Huang, et al.
Cell Reports|November 24, 2025
Dual inhibition of FACT and RRM2 suppresses the progression of pancreatic ductal adenocarcinoma driven by the oncohistone H2BG53DTiantian Qin, Yi Ching Esther Wan, Shiman Hu, et al.
The Journal of Biological Chemistry|February 6, 2021
The elevated transcription of ADAM19 by the oncohistone H2BE76K contributes to oncogenic properties in breast cancerTze Zhen Evangeline Kang, Lina Zhu, Du Yang, et al.
Science Advances|July 10, 2026
H2BE113K mutation promotes breast cancer metastasis through modulating chromatin dynamicsShiman Hu 胡诗曼, Jiaxian Liu, Jiaqi Zhou, et al.
Pageof 1